Oral Temperature Changes in Head and Neck Cancer Patients Predicts Side...
Slight temperature increases of the oral mucus membranes early in a head and neck cancer patient's chemotherapy and radiation therapy (chemoradiotherapy) treatment is a predictor of severe mucositis...
View ArticleNewer Radiation Technology Improves Head and Neck Cancer Patients' Long-Term...
Patients treated with IMRT for head and neck cancer report an increasingly better quality of life post-treatment when compared to patients receiving other forms of radiation therapy, according to a...
View ArticleAstro Develops Brain Metastases Guideline
The American Society for Radiation Oncology (ASTRO) has developed a guideline on the radiotherapeutic and surgical management for newly diagnosed brain metastases. It has been published in Practical...
View ArticleIMRT Reduces Risk of Side Effects in Breast Cancer Patients
Breast cancer patients treated with intensity modulated radiation therapy (IMRT) instead of standard whole breast irradiation (WBI) have a lower incidence of acute or chronic toxicities, according to a...
View ArticleBreast Cancer Patients Choosing Surgery Without Learning Their Options
Surgeons are not always including radiation oncologists early enough in a patient's treatment decision-making process, leaving some patients uninformed of all of their treatment options and potentially...
View ArticleAntioxidant Beta-Carotene Use Safe During Radiation Treatment for Prostate...
Despite past safety concerns, the antioxidant supplement beta-carotene, is safe to use during radiation therapy treatments for prostate cancer and does not increase the risk of prostate cancer death or...
View ArticleASTRO Honored with Two Hermes Awards
The American Society for Radiation Oncology (ASTRO) has been honored with two 2012 Hermes Creative Awards from the Association of Marketing and Communication Professionals (AMCP) for its work on the...
View ArticleASTRO Wins 2012 Communicator Award
The American Society for Radiation Oncology (ASTRO) has been honored with a Communicator Award for its work on the fall 2011 edition of ASTROnews. This publication was recognized with an Award of...
View ArticleCassady, Chen, Dewhirst to be Honored with ASTRO Gold Medals
The American Society for Radiation Oncology (ASTRO) has selected J. Robert Cassady, MD, FASTRO, George T.Y. Chen, PhD, FASTRO, and Mark W. Dewhirst, DVM, PhD, FASTRO, as the Society's 2012 Gold Medal...
View ArticleAccelerated Radiation Treatment Effective for Noninvasive Breast Cancer
Accelerated whole breast irradiation after lumpectomy is an effective treatment for ductal carcinoma in situ (DCIS), a very common early stage and noninvasive form of breast cancer, meaning many more...
View ArticleASTRO to Release Member Survey Results on Impact of Medicare Cuts
The American Society for Radiation Oncology (ASTRO) will release the results of its online member survey conducted earlier this month. ASTRO CEO Laura Thevenot and radiation oncologist Connie Mantz,...
View ArticleUrology-Owned Radiation Oncology Self-Referral Can Increase Patients' Travel...
Men with prostate cancer in Texas may be driving more than three times farther than needed to obtain radiation oncology treatments for their cancer when treated at a urology-owned radiation oncology...
View ArticleTop Cancer Treatment Research Will Be Presented at ASTRO's Annual Meeting
Five webcast news briefings to highlight innovative studies.
View ArticleNational Registry for Radiation Oncology Pilot Program Seeks to Advance...
The National Radiation Oncology Registry (NROR) pilot program will serve as the basis for the creation of a nationwide electronic registry to capture reliable, population-based information on radiation...
View ArticleDiffusion Abnormality Index Provides Potential Imaging Biomarker to Indicate...
Diffusion abnormality index (DAI) shows promise as an imaging biomarker to measure brain tumor response to radiation therapy, according to research being presented at the 2013 Cancer Imaging and...
View ArticleCT Texture Analysis of Tumors May Be a Valuable Biomarker in Localized...
CT texture analysis of primary tumors may be a potential imaging biomarker in localized esophageal cancer following neoadjuvant chemotherapy, according to research being presented at the 2013 Cancer...
View ArticleHepatic Function Testing, Measured by HIDA via SPECT Prior to and During...
Monitoring the hepatic function of unresectable liver cancer patients, measured by 99mTc-labeled iminodiacetic acid (HIDA) via single-photon emission computed tomography (SPECT) prior to and during...
View ArticleSUVmax Provides Valuable Indicator of Progression-Free Survival in Stage I...
SUVmax (Maximum Standardized Uptake Value) may be a significant and clinically independent marker to indicate progression-free survival in stage I non-small cell lung cancer (NSCLC) patients treated...
View ArticleNew ASTRO White Paper Recommends Peer Review to Increase Quality Assurance...
The American Society for Radiation Oncology (ASTRO) has issued a new white paper, "Enhancing the role of case-oriented peer review to improve quality and safety in radiation oncology: Executive...
View ArticleNew ASTRO White Paper Recommends Best Practices for IGRT
To improve safety and effectiveness of image guided radiation therapy (IGRT).
View Article
